Michael F. Haller - Concepedia

Author

Michael F. Haller

Halozyme Therapeutics (United States)

Also Known As

M. F. Haller, M.F. Haller, MICHAEL HALLER, Michael F Haller, Michael F. Haller, Michael Haller, Michael F. Haller

Publications

790

Citations

H-Index

Concepts

All Affiliations

Halozyme Therapeutics (United States)Association des Operateurs Postaux Publics Europeens Rockwell Automation (United States)University of Georgia City of Hope

About

Michael F. Haller is an author at Halozyme Therapeutics (United States) specializing in medicine, pharmacology, and biomolecular engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	506
2	Natural Sciences	5	5	384
3	Biochemistry	5	5	384
4	Engineering	3	3	138
5	Anesthesia	2	2	95

Michael F. Haller

Publications

696

Citations

H-Index

Page 1

	Year	Citations
A recombinant human enzyme for enhanced interstitial transport of therapeutics Louis H. Bookbinder, Anthony Hofer, Michael F. Haller, Journal of Controlled Release Cell-based Drug DeliveryBiochemistryMedicineMembrane TransportNatural Sciences	2006	259
Subcutaneous Drug Delivery Samuel S. Dychter, David Gold, Michael F. Haller Journal of Infusion Nursing Tissue EngineeringEngineeringPharmacotherapyBiomedical EngineeringDermatology	2012	69
Efficacy of Paclitaxel Released From Bio-Adhesive Polymer Microspheres on Model Superficial Bladder Cancer Catherine Le Visage, Nathalie Rioux‐Leclercq, Michael F. Haller, The Journal of Urology	2004	56
Assessing the Role of Human Recombinant Hyaluronidase in Gravity-Driven Subcutaneous Hydration: The INFUSE-LR Study Jay R. Thomas, Richard C. Yocum, Michael F. Haller, Journal of Palliative Medicine Tissue EngineeringEngineeringSurgeryBiomedical EngineeringSubcutaneous Hydration	2007	55
Towards a modular approach for heparin synthesis Michael F. Haller, Geert‐Jan Boons Journal of the Chemical Society Perkin Transactions 1 Selective OxidationCombinatorial ChemistryMedicinal ChemistryBioorganic ChemistryBiochemistry	2001	51
Selectively Protected Disaccharide Building Blocks for Modular Synthesis of Heparin Fragments Michael F. Haller, Geert‐Jan Boons European Journal of Organic Chemistry Bioorganic ChemistryGlycobiologyPolysaccharideDisaccharide Building BlocksModular Approach	2002	42
The INFUSE-Morphine Study: Use of Recombinant Human Hyaluronidase (rHuPH20) to Enhance the Absorption of Subcutaneously Administered Morphine in Patients with Advanced Illness Jay R. Thomas, Mark S. Wallace, Richard C. Yocum, Journal of Pain and Symptom Management Local PharmacologyPharmacologyInfuse-morphine StudyAdvanced IllnessPharmacotherapy	2009	40
In vitro release of vascular endothelial growth factor from gadolinium‐doped biodegradable microspheres Anthony Z. Faranesh, Monet T. Nastley, Cristina Perez de la Cruz, Magnetic Resonance in Medicine	2004	39
The INFUSE-Morphine IIB Study: Use of Recombinant Human Hyaluronidase (rHuPH20) to Enhance the Absorption of Subcutaneous Morphine in Healthy Volunteers Jay R. Thomas, Richard C. Yocum, Michael F. Haller, Journal of Pain and Symptom Management Recombinant Human HyaluronidaseMedicineInfuse-morphine Iib StudyClinical PharmacologyPharmacotherapy	2009	23
Synthesis Development of the Selective Estrogen Receptor Degrader (SERD) LSZ102 from a Suzuki Coupling to a C–H Activation Strategy Markus Baenziger, Marcel Baierl, Krishnaswamy Devanathan, Organic Process Research & Development C–h Activation StrategyOrganic ChemistryPharmaceutical ChemistryHiga CyclizationMolecular Pharmacology	2020	18

Page 1